Clinical trial · Interventional
Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors
Feasibility and Acceptability of a Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors
NCT03722030CI-TRIAL-00053267completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This 2-arm pilot trial will enroll 40 participants to test the feasibility, adherence, and benefits of a home-based strength training intervention for endometrial cancer survivors relative to a wait-listed control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Baseline Measures | Other | — | UNRESOLVED |
| Mid-point Measures | Other | — | UNRESOLVED |
| Post-Study Measures | Other | — | UNRESOLVED |
| Strength-Training | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Strength-Training Intervention
- description
- Following baseline measures, participants will receive an initial in-person instructional session, instructional material and resistance training equipment, support and feedback via video coaching, mid-point assessment, and an in-person study visit to collect post study measures. Intervention will be 10 weeks, with a 5 week follow up period.
- interventionNames
- Other: Baseline Measures
- Behavioral: Strength-Training
- Other: Mid-point Measures
- Other: Post-Study Measures
- type
- PLACEBO_COMPARATOR
- label
- Waitlist Control
- description
- Following baseline measures, participants will provide mid-point measures, and in-person post-study measures with no 10-week strength training intervention.
- interventionNames
- Other: Baseline Measures
- Other: Mid-point Measures
- Other: Post-Study Measures
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Willing to provide written informed consent * Willing to comply with all study procedures and be available for the duration of the study * Fluent in spoken and written English * Documented diagnosis of Type I, stage I-IIIc endometrial cancer within the past 5 years * Completion of current treatment for endometrial cancer, period of time of ≥10 weeks from treatment completion to study enrollment is required Exclusion Criteria: * Absolute contraindications to exercise (i.e., acute myocardial infarction, severe orthopedic or musculoskeletal limitations * Have evidence of recurrent or metastatic disease * Are currently performing resistance training ≥2 days per week * Report of chest pain, shortness of breath, fainting, or angina pectoris * Have physical disability that would limit range of motion through exercises such as sitting, standing and inability to walk one block * Plans to move from the area * Enrolled in another clinical trial or has used of any investigational drugs, biologics, or devices within 30 days prior to randomization * Women who are pregnant or breast-feeding * Not suitable for study participation due to other reasons at the discretion of the investigator
References
Publications (0)
Data not yet available
No reference posted for this study.